Nano-Copper Particles
The research report includes specific segments by region (country), by manufacturers, by Size and ... Read More
Global Patient-derived Xenograft (PDX) Models Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Mouse Model
1.2.3 Rat Model
1.3 Market by Application
1.3.1 Global Patient-derived Xenograft (PDX) Models Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Preclinical Drug development
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient-derived Xenograft (PDX) Models Market Perspective (2017-2028)
2.2 Patient-derived Xenograft (PDX) Models Growth Trends by Region
2.2.1 Patient-derived Xenograft (PDX) Models Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Patient-derived Xenograft (PDX) Models Historic Market Size by Region (2017-2022)
2.2.3 Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2023-2028)
2.3 Patient-derived Xenograft (PDX) Models Market Dynamics
2.3.1 Patient-derived Xenograft (PDX) Models Industry Trends
2.3.2 Patient-derived Xenograft (PDX) Models Market Drivers
2.3.3 Patient-derived Xenograft (PDX) Models Market Challenges
2.3.4 Patient-derived Xenograft (PDX) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue
3.1.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue (2017-2022)
3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2017-2022)
3.2 Global Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient-derived Xenograft (PDX) Models Revenue
3.4 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio
3.4.1 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient-derived Xenograft (PDX) Models Revenue in 2021
3.5 Patient-derived Xenograft (PDX) Models Key Players Head office and Area Served
3.6 Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
3.7 Date of Enter into Patient-derived Xenograft (PDX) Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient-derived Xenograft (PDX) Models Breakdown Data by Type
4.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Type (2017-2022)
4.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2023-2028)
5 Patient-derived Xenograft (PDX) Models Breakdown Data by Application
5.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Application (2017-2022)
5.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Patient-derived Xenograft (PDX) Models Market Size (2017-2028)
6.2 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size (2017-2028)
7.2 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size (2017-2028)
8.2 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
8.3 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Patient-derived Xenograft (PDX) Models Market Size (2017-2028)
9.2 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
9.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size (2017-2028)
10.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
10.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Introduction
11.1.4 Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.1.5 Crown Bioscience Recent Development
11.2 Champions Oncology
11.2.1 Champions Oncology Company Detail
11.2.2 Champions Oncology Business Overview
11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Introduction
11.2.4 Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.2.5 Champions Oncology Recent Development
11.3 Wuxi Apptec
11.3.1 Wuxi Apptec Company Detail
11.3.2 Wuxi Apptec Business Overview
11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Introduction
11.3.4 Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.3.5 Wuxi Apptec Recent Development
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Detail
11.4.2 The Jackson Laboratory Business Overview
11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Introduction
11.4.4 The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.4.5 The Jackson Laboratory Recent Development
11.5 EPO Berlin-Buch
11.5.1 EPO Berlin-Buch Company Detail
11.5.2 EPO Berlin-Buch Business Overview
11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Introduction
11.5.4 EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.5.5 EPO Berlin-Buch Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Detail
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Introduction
11.6.4 Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.6.5 Oncodesign Recent Development
11.7 Xentech
11.7.1 Xentech Company Detail
11.7.2 Xentech Business Overview
11.7.3 Xentech Patient-derived Xenograft (PDX) Models Introduction
11.7.4 Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.7.5 Xentech Recent Development
11.8 Envigo
11.8.1 Envigo Company Detail
11.8.2 Envigo Business Overview
11.8.3 Envigo Patient-derived Xenograft (PDX) Models Introduction
11.8.4 Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.8.5 Envigo Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Detail
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Introduction
11.9.4 Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.9.5 Charles River Laboratories Recent Development
11.10 Pharmatest Services
11.10.1 Pharmatest Services Company Detail
11.10.2 Pharmatest Services Business Overview
11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Introduction
11.10.4 Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.10.5 Pharmatest Services Recent Development
11.11 Urosphere
11.11.1 Urosphere Company Detail
11.11.2 Urosphere Business Overview
11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Introduction
11.11.4 Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.11.5 Urosphere Recent Development
11.12 MEDICILON
11.12.1 MEDICILON Company Detail
11.12.2 MEDICILON Business Overview
11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Introduction
11.12.4 MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.12.5 MEDICILON Recent Development
11.13 Horizon Discovery
11.13.1 Horizon Discovery Company Detail
11.13.2 Horizon Discovery Business Overview
11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Introduction
11.13.4 Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.13.5 Horizon Discovery Recent Development
11.14 Shanghai Model Organisms Center
11.14.1 Shanghai Model Organisms Center Company Detail
11.14.2 Shanghai Model Organisms Center Business Overview
11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Introduction
11.14.4 Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.14.5 Shanghai Model Organisms Center Recent Development
11.15 GemPharmatech
11.15.1 GemPharmatech Company Detail
11.15.2 GemPharmatech Business Overview
11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Introduction
11.15.4 GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.15.5 GemPharmatech Recent Development
11.16 LIDE Biotech
11.16.1 LIDE Biotech Company Detail
11.16.2 LIDE Biotech Business Overview
11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Introduction
11.16.4 LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022)
11.16.5 LIDE Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Mouse Model
Table 3. Key Players of Rat Model
Table 4. Global Patient-derived Xenograft (PDX) Models Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2017-2022)
Table 8. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2023-2028)
Table 10. Patient-derived Xenograft (PDX) Models Market Trends
Table 11. Patient-derived Xenograft (PDX) Models Market Drivers
Table 12. Patient-derived Xenograft (PDX) Models Market Challenges
Table 13. Patient-derived Xenograft (PDX) Models Market Restraints
Table 14. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Patient-derived Xenograft (PDX) Models Market Share by Players (2017-2022)
Table 16. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2021)
Table 17. Ranking of Global Top Patient-derived Xenograft (PDX) Models Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Patient-derived Xenograft (PDX) Models Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
Table 21. Date of Enter into Patient-derived Xenograft (PDX) Models Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2017-2022)
Table 25. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2023-2028)
Table 27. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2017-2022)
Table 29. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2023-2028)
Table 31. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2023-2028) & (US$ Million)
Table 41. Crown Bioscience Company Detail
Table 42. Crown Bioscience Business Overview
Table 43. Crown Bioscience Patient-derived Xenograft (PDX) Models Product
Table 44. Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 45. Crown Bioscience Recent Development
Table 46. Champions Oncology Company Detail
Table 47. Champions Oncology Business Overview
Table 48. Champions Oncology Patient-derived Xenograft (PDX) Models Product
Table 49. Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 50. Champions Oncology Recent Development
Table 51. Wuxi Apptec Company Detail
Table 52. Wuxi Apptec Business Overview
Table 53. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product
Table 54. Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 55. Wuxi Apptec Recent Development
Table 56. The Jackson Laboratory Company Detail
Table 57. The Jackson Laboratory Business Overview
Table 58. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product
Table 59. The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 60. The Jackson Laboratory Recent Development
Table 61. EPO Berlin-Buch Company Detail
Table 62. EPO Berlin-Buch Business Overview
Table 63. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product
Table 64. EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 65. EPO Berlin-Buch Recent Development
Table 66. Oncodesign Company Detail
Table 67. Oncodesign Business Overview
Table 68. Oncodesign Patient-derived Xenograft (PDX) Models Product
Table 69. Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 70. Oncodesign Recent Development
Table 71. Xentech Company Detail
Table 72. Xentech Business Overview
Table 73. Xentech Patient-derived Xenograft (PDX) Models Product
Table 74. Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 75. Xentech Recent Development
Table 76. Envigo Company Detail
Table 77. Envigo Business Overview
Table 78. Envigo Patient-derived Xenograft (PDX) Models Product
Table 79. Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 80. Envigo Recent Development
Table 81. Charles River Laboratories Company Detail
Table 82. Charles River Laboratories Business Overview
Table 83. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product
Table 84. Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 85. Charles River Laboratories Recent Development
Table 86. Pharmatest Services Company Detail
Table 87. Pharmatest Services Business Overview
Table 88. Pharmatest Services Patient-derived Xenograft (PDX) Models Product
Table 89. Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 90. Pharmatest Services Recent Development
Table 91. Urosphere Company Detail
Table 92. Urosphere Business Overview
Table 93. Urosphere Patient-derived Xenograft (PDX) ModelsProduct
Table 94. Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 95. Urosphere Recent Development
Table 96. MEDICILON Company Detail
Table 97. MEDICILON Business Overview
Table 98. MEDICILON Patient-derived Xenograft (PDX) ModelsProduct
Table 99. MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 100. MEDICILON Recent Development
Table 101. Horizon Discovery Company Detail
Table 102. Horizon Discovery Business Overview
Table 103. Horizon Discovery Patient-derived Xenograft (PDX) ModelsProduct
Table 104. Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 105. Horizon Discovery Recent Development
Table 106. Shanghai Model Organisms Center Company Detail
Table 107. Shanghai Model Organisms Center Business Overview
Table 108. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) ModelsProduct
Table 109. Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 110. Shanghai Model Organisms Center Recent Development
Table 111. GemPharmatech Company Detail
Table 112. GemPharmatech Business Overview
Table 113. GemPharmatech Patient-derived Xenograft (PDX) ModelsProduct
Table 114. GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 115. GemPharmatech Recent Development
Table 116. LIDE Biotech Company Detail
Table 117. LIDE Biotech Business Overview
Table 118. LIDE Biotech Patient-derived Xenograft (PDX) ModelsProduct
Table 119. LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2017-2022) & (US$ Million)
Table 120. LIDE Biotech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient-derived Xenograft (PDX) Models Market Share by Type: 2021 VS 2028
Figure 2. Mouse Model Features
Figure 3. Rat Model Features
Figure 4. Global Patient-derived Xenograft (PDX) Models Market Share by Application in 2021 & 2028
Figure 5. Preclinical Drug development Case Studies
Figure 6. Biomarker Analysis Case Studies
Figure 7. Patient-derived Xenograft (PDX) Models Report Years Considered
Figure 8. Global Patient-derived Xenograft (PDX) Models Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Patient-derived Xenograft (PDX) Models Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Patient-derived Xenograft (PDX) Models Market Share by Region: 2021 VS 2028
Figure 11. Global Patient-derived Xenograft (PDX) Models Market Share by Players in 2021
Figure 12. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2021
Figure 14. North America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Patient-derived Xenograft (PDX) Models Market Share by Country (2017-2028)
Figure 16. United States Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Patient-derived Xenograft (PDX) Models Market Share by Country (2017-2028)
Figure 20. Germany Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Share by Region (2017-2028)
Figure 28. China Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Patient-derived Xenograft (PDX) Models Market Share by Country (2017-2028)
Figure 36. Mexico Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Country (2017-2028)
Figure 40. Turkey Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Crown Bioscience Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 43. Champions Oncology Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 44. Wuxi Apptec Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 45. The Jackson Laboratory Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 46. EPO Berlin-Buch Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 47. Oncodesign Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 48. Xentech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 49. Envigo Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 50. Charles River Laboratories Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 51. Pharmatest Services Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 52. Urosphere Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 53. MEDICILON Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 54. Horizon Discovery Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 55. Shanghai Model Organisms Center Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 56. GemPharmatech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 57. LIDE Biotech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Crown Bioscience Champions Oncology Wuxi Apptec The Jackson Laboratory EPO Berlin-Buch Oncodesign Xentech Envigo Charles River Laboratories Pharmatest Services Urosphere MEDICILON Horizon Discovery Shanghai Model Organisms Center GemPharmatech LIDE Biotech